13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Changes in magnetic resonance mammography due to hormone replacement therapy

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The aim of the present article is to investigate effects of hormone replacement therapy (HRT) on contrast medium enhancement patterns in postmenopausal patients during magnetic resonance mammography (MRM).

          Materials and methods

          Two hundred and fifteen patients receiving hormonal medication were divided into four groups: 150 patients with 1 MRM during HRT (group A), 13 patients with 2 MRMs under HRT (group B), 30 patients with 1 MRM during HRT and 1 MRM after HRT withdrawal (group C), and 22 women with 1 MRM after HRT withdrawal (group D). Dynamic MRM was performed at 1.5 Tesla. Signal intensity changes were characterized by five time curves: minimal enhancement (type I), weak continuous enhancement (type II), strong continuous enhancement (type III), and a steep initial slope followed by a plateau phenomenon (type IV) or a washout effect (type V).

          Results

          Of all 193 patients under HRT (group A + group B + group C), 60 patients (31.1%) showed curve type I, 88 patients (45.6%) showed type II and 45 patients (23.3%) showed type III. There were significant differences to 52 patients after HRT withdrawal (group C + group D) ( P < 0.0001), with 42 patients (80.8%) for curve type I, 8 patients (15.4%) for type II, and 2 patients (3.8%) for type III. In both MRM sessions in group B, 69% of the patients showed identical curve types without significant differences ( P = 0.375). In group C, 28 of 30 patients (93%) dropped to lower curve types with significant differences in curve types during and after HRT ( P < 0.0001).

          Conclusion

          The majority of patients receiving postmenopausal HRT showed bilateral symmetrical, continuous enhancement without evidence of a plateau phenomenon or a washout effect due to HRT in MRM. Hormonal effects could be proven and were reproducible and reversible.

          Related collections

          Most cited references30

          • Record: found
          • Abstract: not found
          • Article: not found

          Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations.

            Of a total of 191 magnetic resonance breast studies performed since March 1984, 82 were performed with gradient-echo fast low-angle shot (FLASH) sequences and fast imaging with steady precession (FISP). These techniques permit imaging of thin and contiguous sections, resulting in high resolution of the parenchymal structure. Intravenous injection of 0.1 mmol/kg of gadolinium diethylenetriamine-pentaacetic acid dimeglumine (50% of the dose used in spin-echo sequences) aided in detection of carcinomas as small as 3 mm in dense breast tissue. In 25 patients, dynamic studies were performed at short intervals after the injection of contrast medium in an attempt to differentiate more reliably between breast tissue types. All six malignant tumors found in these 25 patients showed enhancement characterized by a sudden increase in signal intensity on the order of 100% within the first 2 minutes after injection and a much slighter increase thereafter. Sixteen benign lesions showed a substantially different pattern of enhancement. Further studies are required to confirm these findings.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency.

              To define the range of normal contrast medium enhancement, the variability in contrast medium enhancement patterns in healthy premenopausal breast parenchyma, and the implications for management strategies in cases with incidental contrast medium-enhancing foci on breast magnetic resonance (MR) images. Twenty healthy volunteers (aged 21-41 years) were examined on a 1.5-T system (dynamic two-dimensional gradient-echo protocol with subtraction postprocessing) during each week of a menstrual cycle (group 1) or over 4 months (group 2). The authors evaluated changes in the number of enhancing foci and the respective enhancement patterns within a cycle and between cycles. Both diffuse and nodular enhancement of breast parenchyma occurred during all phases of the menstrual cycle, especially in weeks 1 and 4. Enhancement was lowest in week 2. A total of 60 enhancing foci (73% of which resolved completely during follow-up) were found in 16 of 20 volunteers. Twenty-six foci demonstrated enhancement velocities beyond the malignancy threshold (>80% increase in the 1st minute). Contrast-enhancing foci are normal in healthy premenopausal breasts, even when formal malignancy criteria of enhancement velocity are met. This has to be kept in mind to avoid false-positive results, especially in younger patients.
                Bookmark

                Author and article information

                Journal
                Breast Cancer Res
                Breast Cancer Research
                BioMed Central (London )
                1465-5411
                1465-542X
                2004
                16 March 2004
                : 6
                : 3
                : R232-R238
                Affiliations
                [1 ]Institute of Diagnostic and Interventional Radiology, Friedrich-Schiller-University, Jena, Germany
                Article
                bcr779
                10.1186/bcr779
                400676
                15084246
                1347eaec-cffe-4a2f-a2ef-86efc2259c6c
                Copyright © 2004 Pfleiderer et al., licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
                History
                : 19 November 2003
                : 8 January 2004
                : 14 January 2004
                : 24 February 2004
                Categories
                Research Article

                Oncology & Radiotherapy
                breast,magnetic resonance imaging,ductal carcinoma in situ,hormone replacement therapy,breast cancer

                Comments

                Comment on this article